Advances and challenges: dendritic cell vaccination strategies for glioblastoma.

  title={Advances and challenges: dendritic cell vaccination strategies for glioblastoma.},
  author={Teilo H Schaller and John H. Sampson},
  journal={Expert review of vaccines},
  volume={16 1},
INTRODUCTION Glioblastoma is the most common primary brain tumor in adults and prognosis remains poor with a median survival of approximately 15-17 months. This review provides an overview of recent advances in the field of glioblastoma immunotherapy. Areas covered: Recent advances in dendritic cell vaccination immunotherapy are showing encouraging results in clinical trials and promise to extend patient survival. In this report we discuss current scientific knowledge regarding dendritic cell… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…